Drug Shortage Report for NEUPOGEN
| Report ID | 250477 |
| Drug Identification Number | 01968017 |
| Brand name | NEUPOGEN |
| Common or Proper name | filgrastim injection |
| Company Name | AMGEN CANADA INC |
| Market Status | MARKETED |
| Active Ingredient(s) | FILGRASTIM |
| Strength(s) | 300MCG |
| Dosage form(s) | SOLUTION |
| Route of administration | SUBCUTANEOUS INTRAVENOUS SUBCUTANEOUS INTRAVENOUS |
|
Packaging sizes (GTIN)
Click here to see a list of all reports for this drug. |
(See additional packaging sizes) |
| Additional packaging sizes | 1.0 mL and 1.6 mL vials |
| ATC code | L03AA |
| ATC description | IMMUNOSTIMULANTS |
| Reason for shortage | Other (Please describe in comments) |
| Anticipated start date | |
| Actual start date | 2025-02-14 |
| Estimated end date | 2025-03-24 |
| Actual end date | 2025-03-24 |
| Shortage status | Resolved |
| Updated date | 2025-03-25 |
| Company comments | Expiry date revision |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 6775 FINANCIAL DRIVE MISSISSAUGA, ONTARIO CANADA L5N 0A4 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v5 | 2025-03-25 | English | Compare |
| v4 | 2025-03-24 | French | Compare |
| v3 | 2025-03-24 | English | Compare |
| v2 | 2025-02-17 | French | Compare |
| v1 | 2025-02-17 | English | Compare |
Showing 1 to 5 of 5